|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Response of blood pressure after percutaneous transluminal renal artery angioplasty and stenting显示文摘AIM: To evaluate the short and intermediate term out-come of percutaneous transluminal renal artery angioplasty (PTRA) and stenting particularly on blood pressure (BP) control and renal function and to evaluate predictors of poor BP response after successful PTRA and stenting. METHODS: We conducted a prospective analysis of all patients who underwent PTRA and stenting in our institute between August 2010 to September 2012. A total number of 86 patients were underwent PTRA and renal stenting. Selective angiography was done to confirm at least 70% angiographic stenosis. The predilatation done except few cases with critical stenosis, direct stenting was done in the rest of cases. All patients received aspirin 325 mg orally, and clopidogrel 300 mg orally within 24 h before the procedure. Heparin was used as the procedural anticoagulant agent. Optimal results with TIMI-Ⅲ flow obtained in all cases. Following stent placement, aspirin 150 mg orally once daily was continued for a minimum of 12 mo and clopidogrel 75 mg orally once daily for at least 4 wk. The clinical, radiological, electrocardiography, echocardiography and treatment data of all patients were recorded. The BP measurement, serum creatinine and glomerular filtration rate (GFR) were recorded before the procedure and 1 and 6 mo after PTRA. RESULTS: A total of 86 patients were included in the study. The mean age of study population was 55.87±11.85 years old and 67 (77.9%) of patients were male. There was a significant reduction in both systolic and diastolic BP at 1 mo after the procedure: 170.15±20.10 mmHg vs 146.60±17.32 mmHg and 98.38±10.55 mmHg vs 89.88±9.22 mmHg respectively (P=0.0000). The reduction in BP was constant throughout the follow-up period and was evident 6 mo after the procedure: 144.23±18.19 and 88.26±9.79 mmHg respectively (P=0.0000). However, no improvement in renal function was observed at any time during the follow-up period. After multivariate analysis, we found male sex, low GFR (<60 mL/min) and higher baseline mean BP as a poor predictors of successful outcome on BP response after PTRA and stenting. CONCLUSION: The PTRA and stenting can be considered as an effective therapeutic intervention for improving BP control with minimal effect on renal function. The male sex, higher baseline BP and low GFR are associated with poor BP response after successful PTRA and stenting. | Jayesh S Prajapati Sharad R Jain Hasit Joshi Shaurin Shah Kamal Sharma Sibasis Sahoo Kapil Virparia Ashok Thakkar | 2013 | World Journal of Cardiology2013，5，7： | 3 |
| 2 | Alkaline unfolding and saltinduced folding of bovine liver eatalase at high pH显示文摘 | Prajapati S Bhakuni V Babu K R | 1998 | Eur J Biochem1998，255，1： | 1 |
| 3 | Pesticide residue in water-a challenging task inIndia 显示文摘 | Agarwal A Prajapati R Singh O P | 2015 | Environmental Monitoring and Assessment2015，187，2： | 1 |
| 4 | Fastdissolving films (FDFs) as a newer venture in fast dissolvingdosage forms 显示文摘 | Patel A R Prajapati D S Raval J A | 2010 | lnt J Drug Dev Res2010，2，2： | 1 |
| 5 | Immunomodulatory effects of probiotics in the treatment of human immunodeficiency virus(HIV)infection显示文摘 | Patel A R Shah N P Prajapati J B | 2014 | Biomedicine and Preventive Nutrition2014，4，1： | 1 |
| 6 | Effec- tive synthesis of 1, 5-disubstituted-2, 1-benzisothiazol-3 ( 1H)-ones显示文摘 | Kharul R K Prajapati P N Thorave A | 2011 | Syn Corranun2011，41，22： | 1 |
| 7 | Molecular Docking and in Vitro Antileishmanial Evaluation of Chromene-2-thione Analogues显示文摘 | VERMA R K PRAJAPATI V K VERMA G K | 2012 | ACS Med Chem Lett2012，3，3： | 1 |
| 8 | Analytical method development & validation protocol for trospium chloride in tablet dosage form 显示文摘 | Bendale A R Prajapati V S Narkhede S P | 2011 | Indo- Global Journal of Pharmaceutical Sciences2011，1，2： | 1 |
| 9 | Replication of association of the PTPRC gene with response to anti-tumor necrosis factor thera- py in a large UK eohort显示文摘 | Plant D Prajapati R Hyfieh K L | 2012 | Arthritis Rheum2012，64，3： | 1 |
| 10 | Concentration-dependent reversible self-oligomerization of serum albumins through intermolecular β-sheet formation显示文摘 | Bhattacharya A Prajapati R Chatterjee S | 2014 | Langmuir2014，30，14： | 1 |
| 11 | Comparative Analysis of DES, AES, RSA Encryption Algorithms 显示文摘 | Prajapati P Patel N Macwan R | 2014 | International Journal of Engi- neering and Management Research2014，4，1： | 1 |
| 12 | Studies on energetic compounds: Synthesis and crystal structure of disodium azotetrazole pentahydrate 显示文摘 | SINGH G PRAJAPATI R FROHLICH R | 2005 | J Hazard Mater2005，118，： | 1 |
| 13 | Magnetoelastic behaviour of aluminium substituted terfenol-D at elevated temperature显示文摘 | PRAJAPATI K JENNER A G GREENOUGH R D | 1995 | IEEE Trans Magn1995，31，6： | 1 |
| 14 | Magnetom-echanical behaviour of rare earth iron-aluminium compounds显示文摘 | Prajapati K Jenner A G Greenough R D | 1993 | IEEE Trans Magn1993，29，6： | 1 |
| 15 | Sample Size Estimation and Statistical Power Analysis显示文摘 | PRAJAPATI B DUNNE M ARMSTRONG R | | 0，，： | 1 |
| 16 | Magneto elastic behaviour of aluminium substituted Terfenol-Datelevated temperature显示文摘 | Prajapati K Jenner A G Green Ough R D | 1995 | IEEE Trans Magn1995，31，6： | 1 |
| 17 | Evaluation of bowel wall thickening by computed tomography to differentiate benign from malig- nant lesions 显示文摘 | Tapasvi C Prajapati N Madhok R | 2014 | J Clin Diagn Res2014，8，11： | 1 |
| 18 | Room temperature selective oxidation of eyelohexane over Cu- nanoclusters supported on nanocrystalline Cr2O3显示文摘 | SARKAR B PRAJAPATI P TIWARI R | 2012 | Green Chemistry2012，14，9： | 1 |
| 19 | Leiomyosarcoma of inferior vena cava显示文摘 | Jadhav SA Atluri VS Prajapati R | | 0，，04： | 1 |
| 20 | Genetic and genpmic predictors of anti-TNF response 显示文摘 | Prajapati R Plant D Barton A | 2011 | Pharmacogenomics2011，12，11： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员